Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1251
CSW Industrials
CSW
$4.71B
| $9.5M | 0.01% |
137,500
-19,700
| -13% | -$1.33M |
2016 Q2
16 quarters
|
|
|
ALSK
1252
DELISTED
Alaska Communications Systems
ALSK
| $9.49M | 0.01% |
3,402,086
+445,124
| +15% | +$1.01M |
2014 Q3
23 quarters
|
|
1253
Banco Bradesco
BBD
$45.3B
| $9.49M | 0.01% |
+3,013,579
| New | +$9.17M |
2020 Q2
0 quarters
|
|
1254
Diamondback Energy
FANG
$54.6B
| $9.49M | 0.01% |
226,889
-605,200
| -73% | -$24.7M |
2020 Q1
1 quarter
|
|
1255
Ellington Residential Mortgage REIT
EARN
$128M
| $9.49M | 0.01% |
921,000
+22,700
| +3% | +$204K |
2013 Q4
26 quarters
|
|
1256
Magna International
MGA
$17B
| $9.46M | 0.01% |
212,484
-206,200
| -49% | -$8.15M |
2020 Q1
1 quarter
|
|
1257
SouthState Bank Corp
SSB
$9.77B
| $9.46M | 0.01% |
198,464
+172,382
| +661% | +$9M |
2013 Q3
27 quarters
|
|
1258
Orchid Island Capital
ORC
$997M
| $9.45M | 0.01% |
401,259
-141,480
| -26% | -$2.82M |
2018 Q3
7 quarters
|
|
1259
White Mountains Insurance
WTM
$4.98B
| $9.41M | 0.01% |
10,600
-600
| -5% | -$541K |
2013 Q2
28 quarters
|
|
1260
Eagle Materials
EXP
$5.02B
| $9.41M | 0.01% |
134,000
+14,800
| +12% | +$931K |
2018 Q3
7 quarters
|
|
1261
Protagonist Therapeutics
PTGX
$9.37B
| $9.4M | 0.01% |
532,300
-43,100
| -7% | -$541K |
2018 Q1
9 quarters
|
|
|
LGF.B
1262
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $9.36M | 0.01% |
1,370,234
+66,900
| +5% | +$462K |
2017 Q3
11 quarters
|
|
1263
Tradeweb Markets
TW
$23.3B
| $9.3M | 0.01% |
159,966
-617,081
| -79% | -$35.5M |
2020 Q1
1 quarter
|
|
1264
Enel Chile
ENIC
$6.16B
| $9.3M | 0.01% |
2,466,173
+391,216
| +19% | +$1.48M |
2017 Q1
13 quarters
|
|
1265
Conduent
CNDT
$232M
| $9.29M | 0.01% |
3,888,858
+959,658
| +33% | +$2.23M |
2017 Q3
11 quarters
|
|
|
STAY
1266
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $9.29M | 0.01% |
830,290
+73,190
| +10% | +$767K |
2016 Q4
14 quarters
|
|
1267
Old Second Bancorp
OSBC
$1.26B
| $9.28M | 0.01% |
1,192,925
+46,700
| +4% | +$346K |
2013 Q2
28 quarters
|
|
1268
Regis Corp
RGS
$71.8M
| $9.28M | 0.01% |
56,720
-39,620
| -41% | -$7.43M |
2013 Q2
28 quarters
|
|
1269
Evercore
EVR
$10.5B
| $9.24M | 0.01% |
156,900
-150,800
| -49% | -$8.2M |
2013 Q2
28 quarters
|
|
1270
DELISTED
Zuora, Inc.
ZUO
| $9.23M | 0.01% |
723,700
+81,200
| +13% | +$904K |
2019 Q3
3 quarters
|
|
|
GLIBA
1271
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $9.19M | 0.01% |
129,210
-1,000
| -0.8% | -$64.1K |
2019 Q3
3 quarters
|
|
1272
DELISTED
Chimerix, Inc.
CMRX
| $9.17M | 0.01% |
2,958,289
-291,724
| -9% | -$755K |
2017 Q1
13 quarters
|
|
1273
Dime Commercial Bancshares
DCOM
$1.7B
| $9.17M | 0.01% |
401,500
-4,859
| -1% | -$99.8K |
2014 Q4
22 quarters
|
|
1274
Selective Insurance
SIGI
$5.06B
| $9.15M | 0.01% |
173,594
+37,800
| +28% | +$1.91M |
2018 Q3
7 quarters
|
|
1275
Columbus McKinnon
CMCO
$459M
| $9.11M | 0.01% |
272,385
-16,715
| -6% | -$461K |
2016 Q1
17 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.